Grant Process
Forecasted
The Grant Process from the Ara Parseghian Medical Research Fund supports collaborative research into the molecular mechanisms and new therapies for Niemann Pick Type C disease.
Funder: Ara Parseghian Medical Research Fund
Due Dates (Anticipated): June 2027 (annual application deadline, projected)
Funding Amounts: Awards are typically for up to 1 year; some may be considered for 2 years. Overhead limited to 10%.
Summary: Supports collaborative research on the molecular mechanisms and novel therapies for Niemann Pick Type C disease.
Description
This opportunity supports research aimed at understanding the molecular basis of Niemann Pick Type C (NPC) disease and developing innovative therapeutic strategies. The fund encourages open collaboration among investigators and provides oversight through a Scientific Advisory Board composed of leading experts in genetics, molecular biology, neurology, and pathology. Projects funded through this mechanism are expected to advance knowledge of NPC disease mechanisms and contribute to the development of effective treatments or cures.
